Amphastar Pharmaceuticals, Inc. (AMPH) stock analysis

AMPH · Amphastar Pharmaceuticals, Inc.

Latest recorded price: USD 29.17

Model-estimated fair value: USD 61.95. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic

At $29.17, AMPH trades 52.9% below the model's base-case value of $61.95. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $44.43 in the conservative case and $83.09 in the optimistic case, with a valuation confidence score of 75/100. Fiscal 2025 figures: revenue growth 13.0%, free cash flow margin 16.8%, ROIC 9.5%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare